4[1]Ohgaki N. Bacterial biofilm in chronic airway infection. Kansenshog aku Zasshi,1994,68:138～151.
5[2]Kobayashi H. Biofilm Disease:its clinical manifestation and therape utic possibilities of macrolides. Am J Med,1995,99(6A):26S～36S.
6[4]Costeton JW,Chen KJ,Geesey GG,et al. Bacterial biofilms in nature a nd disease. Ann Rev Microbiol,1987,41:435～464.
7[5]Anwar H, Strap JL,Costerton JW. Establishment of aging biofilms:pos sible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Age nts Chemother,1992,36:1347～1351.
8[6]Anwar H,Dasgupta MK,Costerton JW. Testing the susceptibility of ba cteria in biofilms to antibacterial agents. Antimicrob Agents Chemother,1990,34: 2043～2046.
9[7]Hoyle BD,Alcantara J,Costerton JW. Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrob Agents Chemother,1992,36:2054 ～2056.
10[8]Kumon H,Ono N,Iida M,et al. Combination effect of fosfomycin and of loxacin against pseudomonas aeruginosa growing in a biofilm. Antimicrob Agents C hemother,1995,39:1038～1044.
